Home/Products /glycopyrronium-ip-25-mcg-respule

Glycopyrronium 25mcg Respule in PCD pharma franchise in Hyderabad

Name: Glycopyrronium IP 25 mcg respule
Brand: Glycopyrronium Respule
Rating: 4.8 (150 reviews)

Glycopyrronium 25mcg Respule in pharmaceutical manufacturing company in Mumbai

Glycopyrronium 25mcg Respule in respiratory care pharma franchise in Pune

Glycopyrronium 25mcg Respule in pharma suppliers in Delhi

Glycopyrronium 25mcg Respule in pharma export companies in Kolkata

Glycopyrronium 25mcg Respule in pharma franchise opportunities in Bengaluru

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Glycopyrronium 25mcg Respule | COPD Management | Best Price for PCD Pharma Franchise

Glycopyrronium 25mcg Respule | Anticholinergic Bronchodilator | Best Price from Third-Party Manufacturers in India

Glycopyrronium 25mcg Respule | Respiratory Care | Best Price from Pharma Export Companies in India

Glycopyrronium 25mcg Respule | Pulmonary Segment | Best Price from Top Pharma Company

Glycopyrronium Respule 25mcg | COPD Segment | Best Price in Pulmonary Care Franchise

Glycopyrronium Respule

Composition : Glycopyrronium IP 25 mcg Respule

Dosage Form : Respule

Packaging Type : Pack

Packaging : 4x5x2ml

Price : ₹1/-

Please Contact For Best Price

Glycopyrronium IP 25 mcg Respule is a long-acting muscarinic antagonist (LAMA) bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). It works by blocking the M3 receptors in airway smooth muscles, leading to sustained bronchodilation and improved airflow. The formulation offers effective once-daily maintenance treatment, helping reduce symptoms like breathlessness, wheezing, and chronic cough.

About the Product

Glycopyrronium is usually well tolerated. Some patients may experience dry mouth, constipation, sore throat, or urinary tract infection. Less commonly, dizziness, palpitations, or hypersensitivity reactions may occur. If severe side effects develop, consult a physician immediately.

This respule is indicated for long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is not intended for the relief of acute bronchospasm or as a rescue therapy during sudden breathing difficulty.

Use only as prescribed by a registered medical practitioner. Not to be used for acute episodes of bronchospasm. Do not exceed the recommended dose. Always use with a nebulizer device as directed. Avoid contact with eyes.

Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.